recent pharma news

pharma-happenings-for-merck-abbvie-incyte-aprea-eisai
Merck’s Keytruda Approval; Abbvie’s Venetoclax; Aprea’s Eprenetapopt; CRL to Incyte’s Retif...

FDA Approves Keytruda in Both Adjuvant and Neoadjuvant Setting in High-Risk Early-Stage TNBC In July 2021, the US FDA approved pembrolizumab (Keytruda) for high-risk, early-stage triple-negativ...


Latest-pharma-happenings-for-hepion-nimbus-regeneron-bicycle-therapeutics
Hepion aces mid-stage study; Bicycle Therapeutics-Ionis collaboration; Nimbus raises $105M; Regen...

Hepion Pharma's NASH drug is set for Phase 2b after clearing the safety bar Hepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutic drugs fo...


Latest-pharma-happenings-for-rallybio-sanofi-eureka-lilly-unity-biotechnology
Unity’s advanced vascular eye disease trial; Rallybio raises $100 M; Sanofi bets over $1B f...

UNITY Biotechnology declares positive data from phase 1 clinical trial of UBX1325 in Advanced Vascular Eye Disease patients  UNITY Biotechnology, Inc., a biotechnology company developing t...


recent-pharma-happenings-for-insilico-sanofi-medtronic-blackstone-cellex
Insilico Medicine raises $255M; Sanofi & Translate Bio initiate trial; Medtronic gains expan...

Insilico Medicine raises USD 255 Million for AI drug discovery Insilico Medicine, a Hong Kong-based global leader in end-to-end artificial intelligence for target discovery, small molecule chem...


recent-pharma-happenings-for-mallinckrodt-rayzebio-vectory-umoja
Mallinckrodt earns FDA nod for skin therapy; RayzeBio secures $108M; VectorY raises $38M; Umoja b...

Mallinckrodt earns FDA nod for regenerative skin therapy for burns Mallinckrodt plc’s Stratagraft gained FDA approval for use in deep partial-thickness thermal burns. The company said regenerat...


recent-pharma-news-updates-for-biogen-novo-nordisk-bluebird-bio
Biogen’s Alzheimer’s Drug; FDA approval to Novo Nordisk’s Wegovy; Bluebird’s Gene Therapy

Verdict for Biogen’s Long-Awaited Alzheimer’s Drug Is Finally Here   The USFDA finally gave approval to eagerly-anticipated Biogen’s Drug Aducanumab for the treatment of Alzheimer’s d...


recent-pharma-happenings-for-pfizer-abcellera-sarepta-eli-lilly
Pfizer hit by DMD delay & halts BCMA trials; Sarepta’s drug shows promise in Phase II;...

Pfizer suffers a DMD delay and halts BCMA trials amid safety woes  Pfizer has paused after seeing three cases of peripheral neuropathy in an early-stage study, enrollment in a critical ana...


recent-pharma-biotech-news-updates-happenings-for-abbott-biogen-eli-lilly-arch-oncology
Arch Oncology scores $105M; Abbott’s new coronary imaging platform; Lilly scraps IL-23 psoriasis ...

Arch Oncology scores USD 105 Million for anti-CD47 med in solid tumors, multiple myeloma Arch Oncology scored USD 105 million from new and old backers to expand the drug’s journey through the c...


recent-pharma-biotech-lifescience-healthcare-news-updates-for-vertex-virta-kalvista-ovid-crispr-therapeutics
Vertex leads in CRISPR Therapeutics deal; Update for Phase 2 clinical trial of KVD824; Ovid dumps...

Vertex leads in CRISPR Therapeutics partnership with USD 900 Million upfront Vertex has boosted a deal with CRISPR Therapeutics to USD 900 million upfront as the companies compete against blueb...


recent-pharma-happenings-for-recursion-repertoire-cequr-eli-lilly
Lilly’s Retevmo shows promise; CeQur tanks up on $110M in funding; Repertoire secures $189M; Recu...

Lilly’s RET inhibitor Retevmo exhibits early promise in new cancer types The phase 1/2 LIBRETTO-001 trial enrolled 32 patients with 12 unique RET fusion-positive advanced cancer types, comprisi...


Editor's Pick
Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...

The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...

Emerging Market for Organ on a Chip

The organ on a chip is a microfluidic culture device that recapitulates the complicated...

Global Top Players in Intraocular Lens (IOL) Market

 An Intraocular Lens implant is a synthetic, artificial lens placed inside the eye...

Investigating the Pipeline for Ankylosing Spondylitis Treatment Landscape

Ankylosing Spondylitis is a form of arthritis that primarily affects the spine. It caus...

LAG 3: A Promising Next Generation Cancer Immunotherapy

Immunotherapy also called biologic therapy, is a type of cancer treatment that boosts t...

ASCO Conference 2022
ASCO Conference 2022

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.